[[1] Anastassion X. Psychosis : Causes, Diagnosis and Treatment. New York : Nova Science Publishers. 2012]Search in Google Scholar
[[2] Bresee LC, Majmdar SR, Patten SB, et al. Prevalence of cardiovascular risk factors and disease in people with schizophrenia: A population-based study. In Schizophrenia Research. 2010; 117(1):75-8210.1016/j.schres.2009.12.01620080392]Search in Google Scholar
[[3] Fossa AA. The impact of varying autonomic states on the dynamic beat-to-beat QT-RR and QT-TQ interval relationships. Br J Pharmacol. 2008,154:1508-151510.1038/bjp.2008.123249208918663381]Search in Google Scholar
[[4] Gintant GA, Gallacher DJ, Pugsley MK. The ‘overly-sensitive’ heart: Sodium channel block and QRS interval prolongation. Br J Pharmacol. 2011,164: 254-25910.1111/j.1476-5381.2011.01433.x317440621488862]Search in Google Scholar
[[5] Jones M, Campbell G, Patel D, et al. Risk of Mortality (including Sudden Cardiac Death) and Major Cardiovascular Events in Users of Olanzapine and Other Antipsychotics. Cardiovascular Psychiatry and Neurology. 2013, s. 1-1310.1155/2013/647476387659224416588]Search in Google Scholar
[[6] Lee SH, Kim HR, Han RX, et al. Cardiovascular risk assessment of atypical antipsychotic drugs in a zebrafish model. J. Appl. Toxicol. 2013; 33(6):466-470]Search in Google Scholar
[[7] Moss AJ. The QT interval and torsade de pointes. Drug Saf. 1999, 21(1)10.2165/00002018-199921001-0000210597863]Search in Google Scholar
[[8] Pasterbak B, Svanstrom H, Ranthe MF, et al. Atypical Antipsychotics Olanzapine, Quetiapine, and Risperidone and Risk of Acute Major Cardiovascular Events in Young and Middle-Aged Adults: A Nationwide Register-Based Cohort Study in Denmark. CNS Drugs. 2014; 963-97310.1007/s40263-014-0176-024895158]Search in Google Scholar
[[9] Shafti SS, Jahromi P. Olanzapine induced Q-Tc shortening. Ther Adv Psychopharmacol. 2014; 4(6):240-24610.1177/2045125314546484425798425489475]Search in Google Scholar
[[10] Silvestre JS, O´Neill MF, Prous JR. Evidence for a crucial modulating role of the sodium channel in the QTc prolongation related to antipsychotics. J Psychopharmacol. 2014, (28):329-34010.1177/026988111351506424327451]Search in Google Scholar
[[11] Silvestre JS, Prous JR. Comparative evaluation of hERG potassium channel blockade by antipsychotics. Methods Find Exp Clin Pharmacol. 2007, 29: 457-46510.1358/mf.2007.29.7.111917217982510]Search in Google Scholar
[[12] Taggart P, Sutton P, Chalabi Z, et al. Effect of adrenergic stimulation on action potential duration restitution in humans. Circulation. 2003,107:285-28910.1161/01.CIR.0000044941.13346.74]Search in Google Scholar
[[13] Wang J, Liu YS, Zhu WX, et al. Olanzapine-induced weight gain plays a key role in the potential cardiovascular risk: evidence from heart rate variability analysis. Scientific Reports. 2014 10.1038/srep07394426022525487560]Search in Google Scholar